|
|
|
|
|
By Francisco Conesa Buendía | Here are some updates on the industry's quest to enhance CAR T cells' ability to target and destroy cancer while reducing adverse effects. |
|
|
|
|
| CRISPR And The Commercialization Of Gene-Based Therapies | White Paper | By Andrew Kuhlman, Sean D. Kennedy, and Michael F. Murphy, Ph.D., Worldwide Clinical Trials | Early collaboration between drug developers, manufacturers, and payers is crucial for creating meaningful clinical endpoints and a viable market access strategy. |
|
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
By Carl Accettura, Global Pharma Advisory | A June meeting showed industry is struggling to meet the DSCSA's November deadline. Eligible companies might find relief in an FDA waivers and exemptions program. |
|
|
| 4 Ways To Safeguard Your Supply Of Fetal Bovine Serum | Article | Corning Life Sciences | A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain. |
|
|
|
Connect With Cell & Gene: |
|
|
|